Literature DB >> 3200413

Influence of some monoamine oxidase inhibitors on the sleep-wakefulness cycle of the cat.

T N Oniani1, G R Akhvlediani.   

Abstract

The influence of some monoamine oxidase inhibitors (phenelzine, transamin [tranylcypromine], nialamide) on the structure of the sleep-wakefulness cycle of the cat was studied. It was shown that these monoamine oxidase inhibitors elicit and increase in slow-wave sleep in the sleep-wakefulness cycle due to complete suppression of paradoxical sleep and significant decrease in wakefulness. After the cessation of the action of the monoamine oxidase inhibitors, a selective rebound of wakefulness is observed against the background of complete or partial absence of paradoxical sleep. The gives grounds for the hypothesis that during partial deprivation of wakefulness under the influence of monoamine oxidase inhibitors an intensification occurs on the accumulation of specific need for this physiological state, the satisfaction of which is accomplished as the result of its rebound in the post-deprivational cycle, i.e., after the termination of the EEG of the synchronizing effect of the monoamine oxidase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3200413     DOI: 10.1007/bf01185522

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  12 in total

Review 1.  Is there a sleep transmitter?

Authors:  R R Drucker-Colín; C W Spanis
Journal:  Prog Neurobiol       Date:  1976       Impact factor: 11.685

2.  Phenelzine, mood response, and sleep.

Authors:  D L Dunleavy; I Oswald
Journal:  Arch Gen Psychiatry       Date:  1973-03

3.  The effect of reserpine and monoamine oxidase inhibitors on paradoxical sleep in the monkey.

Authors:  M Reite; G V Pegram; L M Stephens; E C Bixler; O L Lewis
Journal:  Psychopharmacologia       Date:  1969

4.  [Elective suppression of paradoxal sleep in the cat by monoamine oxidase inhibitors].

Authors:  M Jouvet; P Vimont; F Delorme
Journal:  C R Seances Soc Biol Fil       Date:  1965

5.  The respective involvement of noradrenaline and its deaminated metabolites in waking and paradoxical sleep: a neuropharmacological model.

Authors:  B Jones
Journal:  Brain Res       Date:  1972-04-14       Impact factor: 3.252

6.  Mono-amine oxidase inhibitors, sleep and mood.

Authors:  M O Akindele; J I Evans; I Oswald
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1970-07

7.  [Effects of inhibitors of monoamine oxidase on sleep and the electroencephalogram in man].

Authors:  H Cramer; W Kuhlo
Journal:  Acta Neurol Psychiatr Belg       Date:  1967-08

8.  Physiologic and pharmacologic considerations of biogenic amines in the nervous system.

Authors:  F E Bloom; N J Giarman
Journal:  Annu Rev Pharmacol       Date:  1968       Impact factor: 13.820

Review 9.  Neurophysiology of the states of sleep.

Authors:  M Jouvet
Journal:  Physiol Rev       Date:  1967-04       Impact factor: 37.312

10.  Lifetime monoamine oxidase inhibition and sleep.

Authors:  W B Mendelson; R M Cohen; I C Campbell; D L Murphy; J C Gillin; R J Wyatt
Journal:  Pharmacol Biochem Behav       Date:  1982-03       Impact factor: 3.533

View more
  2 in total

Review 1.  The REM sleep-memory consolidation hypothesis.

Authors:  J M Siegel
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

2.  Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile.

Authors:  Joaquín González; José P Prieto; Paola Rodríguez; Matías Cavelli; Luciana Benedetto; Alejandra Mondino; Mariana Pazos; Gustavo Seoane; Ignacio Carrera; Cecilia Scorza; Pablo Torterolo
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.